Generate a tailored SOP for Dr. Yung Chi Cheng. Improve your application with a focused, well-structured draft.
Yung-Chi Cheng is a Professor at the Yale School of Medicine and holds the Henry Bronson Professorship in Pharmacology. His research focuses on developing novel anti-cancer and anti-viral drugs, with significant contributions to the study of various cancers including hepatocellular carcinoma, pancreatic cancer, colorectal cancer, rectal cancer, lung cancer, and melanoma. In anti-viral research, he investigates therapies for hepatitis B and C viruses, human immunodeficiency virus, Epstein Barr virus, and cytomegalovirus. Current efforts in his laboratory employ systems biology approaches to create multi-targeted medicines aimed at treating cancer and aging-related diseases. As part of his commitment to advancing the field of Chinese medicine, Cheng collaborates with several prestigious institutions including the University of Hong Kong, Peking University, and Tsinghua University through the Consortium for Globalization of Chinese Medicine. He has received numerous honors for his contributions to traditional Chinese medicine.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.